PT914043E - Perolas de agarose-colagenio implantaveis contendo celulas que produzem um produto biologico difusivel e suas utilizacoes - Google Patents

Perolas de agarose-colagenio implantaveis contendo celulas que produzem um produto biologico difusivel e suas utilizacoes

Info

Publication number
PT914043E
PT914043E PT97915180T PT97915180T PT914043E PT 914043 E PT914043 E PT 914043E PT 97915180 T PT97915180 T PT 97915180T PT 97915180 T PT97915180 T PT 97915180T PT 914043 E PT914043 E PT 914043E
Authority
PT
Portugal
Prior art keywords
agarose
biological product
colagenean
utilizations
produce
Prior art date
Application number
PT97915180T
Other languages
English (en)
Inventor
Kanti Jain
Albert L Rubin
Shirin Asina
Barry Smith
Kurt Stenzel
Original Assignee
Rogosin Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/745,063 external-priority patent/US5888497A/en
Application filed by Rogosin Inst filed Critical Rogosin Inst
Publication of PT914043E publication Critical patent/PT914043E/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/22Urine; Urinary tract, e.g. kidney or bladder; Intraglomerular mesangial cells; Renal mesenchymal cells; Adrenal gland
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N11/00Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
    • C12N11/02Enzymes or microbial cells immobilised on or in an organic carrier
    • C12N11/04Enzymes or microbial cells immobilised on or in an organic carrier entrapped within the carrier, e.g. gel or hollow fibres
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • C12N5/0602Vertebrate cells
    • C12N5/0693Tumour cells; Cancer cells
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K2035/126Immunoprotecting barriers, e.g. jackets, diffusion chambers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Developmental Biology & Embryology (AREA)
  • Dispersion Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
PT97915180T 1996-04-03 1997-03-21 Perolas de agarose-colagenio implantaveis contendo celulas que produzem um produto biologico difusivel e suas utilizacoes PT914043E (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US62559596A 1996-04-03 1996-04-03
US08/745,063 US5888497A (en) 1996-04-03 1996-11-07 Agarose coated agarose beads containing cancer cells that produce material which suppresses cancer cell proliferation

Publications (1)

Publication Number Publication Date
PT914043E true PT914043E (pt) 2004-02-27

Family

ID=27089961

Family Applications (1)

Application Number Title Priority Date Filing Date
PT97915180T PT914043E (pt) 1996-04-03 1997-03-21 Perolas de agarose-colagenio implantaveis contendo celulas que produzem um produto biologico difusivel e suas utilizacoes

Country Status (16)

Country Link
EP (2) EP0914043B1 (pt)
JP (2) JP3765039B2 (pt)
CN (2) CN1119080C (pt)
AT (2) ATE250858T1 (pt)
AU (1) AU722109C (pt)
CA (1) CA2250880C (pt)
DE (2) DE69725317T2 (pt)
DK (2) DK1382346T3 (pt)
ES (2) ES2206696T3 (pt)
FI (1) FI120332B (pt)
HK (2) HK1019037A1 (pt)
IL (1) IL126442A0 (pt)
NO (1) NO320334B1 (pt)
NZ (2) NZ331960A (pt)
PT (1) PT914043E (pt)
WO (1) WO1997036495A1 (pt)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6303151B1 (en) * 1996-04-03 2001-10-16 The Rogosin Institute Cancer-cell proliferation-suppressing material produced by cancer cells restricted by entrapment
US6224912B1 (en) * 1996-04-03 2001-05-01 The Rogo Institute Cancer-cell proliferation-suppressing material produced by cancer cells restricted by entrapment
US7297331B2 (en) 1996-04-03 2007-11-20 The Rogosin Institute Beads containing restricted cancer cells producing material suppressing cancer cell proliferation
NO983911D0 (no) 1998-08-26 1998-08-26 Norsk Hydro As Alginatkapsler til bruk ved behandling av hjernesvulst
AU2003264652B2 (en) * 1998-11-09 2006-09-14 The Rogosin Institute Compositions of restricted cells capable of rapid growth which produce proliferation suppressive materials, and uses thereof
US8257715B1 (en) 2004-08-26 2012-09-04 University Of Notre Dame Tissue vaccines and uses thereof
US8778360B2 (en) * 2005-10-27 2014-07-15 University Of Notre Dame Extracellular matrix cancer vaccine adjuvant
US8778362B2 (en) 2005-10-27 2014-07-15 University Of Notre Dame Anti-tumor/cancer heterologous acellular collagenous preparations and uses thereof
US8802113B2 (en) 2005-10-27 2014-08-12 University Of Notre Dame Extracellular matrix cancer vaccine adjuvant
US9308252B2 (en) 2005-10-27 2016-04-12 Cook Biotech, Inc. Extracellular matrix materials as vaccine adjuvants for diseases associated with infectious pathogens or toxins
US9283266B2 (en) 2008-02-28 2016-03-15 University Of Notre Dame Metastasis inhibition preparations and methods
US8846059B2 (en) 2009-12-08 2014-09-30 University Of Notre Dame Extracellular matrix adjuvant and methods for prevention and/or inhibition of ovarian tumors and ovarian cancer
PL2809782T3 (pl) * 2012-01-31 2018-04-30 The Rogosin Institute, Inc. Ulepszony sposób wytwarzania makroperełek
AU2019215096A1 (en) * 2018-02-02 2020-08-06 Wake Forest University Health Sciences Organoids related to immunotherapy and methods of preparing and using the same

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE441009B (sv) * 1982-03-08 1985-09-02 Kjell Nilsson Sett att immobilisera levande biomaterial i perlformiga polymerer
US4798786A (en) * 1982-05-06 1989-01-17 Stolle Research And Development Corporation Living cells encapsulated in crosslinked protein
CA1196862A (en) * 1983-06-01 1985-11-19 Anthony M.F. Sun Microencapsulation of living tissue and cells
US4663286A (en) * 1984-02-13 1987-05-05 Damon Biotech, Inc. Encapsulation of materials
SE8604684L (sv) * 1986-11-03 1988-05-04 Excorim Kommanditbolag Sett att belegga fasta partiklar med en hydrofil gel samt genom settet belagda partiklar
JP2691557B2 (ja) * 1988-04-15 1997-12-17 興研株式会社 人の悪性腫瘍細胞増殖抑制剤
US5053332A (en) * 1989-07-24 1991-10-01 Cook Richard B Agarose beads, preferably incorporating biological materials
US5241051A (en) * 1992-04-24 1993-08-31 Research Development Foundation Oncoinhibin
DK1418228T3 (da) * 1994-01-13 2006-07-17 Rogosin Inst Makroindkapslede sekretoriske celler
US5651980A (en) * 1994-04-15 1997-07-29 Biohybrid Technologies, Inc. Methods of use of uncoated gel particles

Also Published As

Publication number Publication date
ATE250858T1 (de) 2003-10-15
NZ331960A (en) 1999-10-28
CN1215309A (zh) 1999-04-28
FI981957A (fi) 1998-12-02
JP3765039B2 (ja) 2006-04-12
CA2250880C (en) 2008-01-15
FI981957A0 (fi) 1998-09-11
CN1495253A (zh) 2004-05-12
EP0914043B1 (en) 2003-10-01
DE69725317D1 (de) 2003-11-06
HK1019037A1 (en) 2000-01-21
DK1382346T3 (da) 2008-01-28
IL126442A0 (en) 1999-08-17
NO984627D0 (no) 1998-10-02
AU2218897A (en) 1997-10-22
JP2005104987A (ja) 2005-04-21
JP2001503380A (ja) 2001-03-13
EP1382346B1 (en) 2007-09-26
DK0914043T3 (da) 2004-02-09
AU722109B2 (en) 2000-07-20
DE69725317T2 (de) 2004-07-29
CA2250880A1 (en) 1997-10-09
DE69738170D1 (de) 2007-11-08
NO320334B1 (no) 2005-11-21
JP4480152B2 (ja) 2010-06-16
AU722109C (en) 2001-07-19
EP0914043A1 (en) 1999-05-12
CN1119080C (zh) 2003-08-27
NO984627L (no) 1998-11-30
WO1997036495A1 (en) 1997-10-09
DE69738170T2 (de) 2008-01-24
FI120332B (fi) 2009-09-30
HK1066026A1 (en) 2005-03-11
EP0914043A4 (en) 2001-08-29
NZ337109A (en) 2004-12-24
ES2206696T3 (es) 2004-05-16
EP1382346A1 (en) 2004-01-21
ES2290390T3 (es) 2008-02-16
ATE374034T1 (de) 2007-10-15
CN1296477C (zh) 2007-01-24

Similar Documents

Publication Publication Date Title
PT914043E (pt) Perolas de agarose-colagenio implantaveis contendo celulas que produzem um produto biologico difusivel e suas utilizacoes
NO902319L (no) Fremgangsmaate for aa bestemme egenskaper vedroerende stroemningsdynamikk for flerfasestroemning.
NO167185C (no) Absorpsjonslegeme av fibre beregnet til bruk i engangsprodukter, samt fremgangsmaate for fremstilling av slike legemer.
NO982722D0 (no) Absorbenter for fosfat fra et vanndig medium, samt fremstilling og anvendelse av absorbenten
DE3685762D1 (de) 3-aryluracile und deren verwendung zur unkrautbekaempfung.
IL68941A0 (en) Method for immobilizing biological materials,composite materials produced thereby and their use
AU3310595A (en) Compositions and methods for identifying biologically active molecules
DE3888642D1 (de) Rollflasche zur Züchtung von Zellengewebekulturen.
DE69007290D1 (de) Absorbierende materialien und deren verwendung.
ES521401A0 (es) Procedimiento de criodesecacion de sustancias cosmeticas y de diagnostico en solucion o suspension en disolventes.
IE830945L (en) Process for obtaining permanently culturable animal and¹human cell lines
AR226964A1 (es) Portas de caldo de cultivo preparados para la determinacion cualitativa y cuantitativa de microorganismos
DE68917154D1 (de) C-terminus-amidierungsenzym-zusammensetzung, verfahren zur herstellung und verwendung.
DE68914522D1 (de) Isobenzothiazolon als chromogenische Thiol-Indikatoren und dessen Derivate.
DE68906992D1 (de) Indanylring enthaltende pyrethinester, deren herstellung und deren anwendung als pestizide.
DE3685743D1 (de) Anthracyclinderivate, ihre verwendung als antitumorsubstanzen und ihre herstellung.
ATE321772T1 (de) Echinocandinderivate, deren herstellung und deren verwendung zur bekämpfung von pilzen
BG46743A3 (en) Method for preparing of alkanoyl anilides
EP0112299A3 (en) Method for superoxidic-dismutasis purification via chromatography by affinity
ES512600A0 (es) "metodo para la determinacion de la actividad de las isoenzimas citoplasmaticas y mitocondriales de la transaminasa glutamico-oxalacetica en suero o plasma humano".
ES533079A0 (es) Procedimiento para la determinacion cuantitativa de la enzima c1 esterasa.
DE69110861D1 (de) Mittel zur verbesserung des kollagenmetabolismus und dessen verwendung.
IT8919650A0 (it) Guarnizione per cuscinetto amovibile.
DK0804098T3 (da) Filter til tobaksrøg
DE58908439D1 (de) Mittel zum Benetzen von hydrophoben, kapillaren Materialien und deren Verwendung.